IQUIX
LOE ApproachingNDAOPHTHALMICSOLUTION/DROPS
Approved
Mar 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
IQUIX is an ophthalmic solution (eye drops) approved in 2004 as a small-molecule NDA by Santen. The specific indication and mechanism of action are not publicly detailed in available data, but the product serves an ophthalmology indication requiring topical ocular administration. IQUIX represents a mature, established therapy in the eye care segment.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30/100), signaling a transition team focused on lifecycle management and market defense rather than growth expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Career opportunities on IQUIX skew toward regulatory, manufacturing, and commercial support roles reflecting a mature product managing LOE transition and global compliance. Hiring is geographically distributed (Asia-Pacific, Eastern Europe) with emphasis on technical specialist and safety vigilance roles, indicating operational and risk-management focus.
[Singapore] Global Safety Vigilance Risk Management Lead
Worked on IQUIX at Santen? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.